Do you analyse common cannabinoids? This application note shows how you can separate a mixture of 11 of the most common cannabinoids using the robust and reproducible YMC-Triart C18 column.

Until recently, cannabis and its derivatives were widely restricted under legislation which stated they had no medical value and carried a substantial risk of misuse. Policy is rapidly changing, and cannabis can now be prescribed for medicinal use in many countries across Europe. This provides important new opportunities for treating patients although these need to be weighed up against potential risks.

Several different medicinal products exist, with contrasting mechanisms of action, efficacy, and safety. Use of these products may increase as new evidence arises and policy changes occur. Certified medicinal cannabis is currently used for the treatment of a number of conditions, including multiple sclerosis, epilepsy, neuropathic pain, arthritis, depression, anxiety disorders, sleep disorders, psychosis, glaucoma and Tourette’s syndrome. It is also used for the relief of symptoms such as nausea and vomiting as a result of chemotherapy, and appetite stimulation in patients suffering from HIV and AIDS.

The cannabinoids form a group of related compounds found in cannabis sativa L, of which over 144 have currently been identified and which exhibit varied effects. THC is generally accepted to be the compound that possesses the psychoactive properties.This application note shows how to separate a mixture of 11 of the most common cannabinoids using the robust and reproducible YMC-Triart C18 column.

For the full method details please download the application note. Visit our homepage or download the YMC-Triart brochure to get further information about the YMC-Triart series.

View | Download App Note

more news from YMC